| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income (expenses) | 65,355 | 74,655 | ||
| Net (loss) before income taxes | -1,021,258 | -1,980,000 | ||
| Provision for income taxes | -137,438 | -209,166 | ||
| Net (loss) | -883,820 | -1,770,834 | ||
| Gain (loss) from foreign exchange translation | -601,628 | 1,084,557 | ||
| Comprehensive (loss) | -1,485,448 | -686,277 | ||
| Earnings per share, diluted | - | -0.82 | ||
| Weighted average number of shares outstanding, diluted | - | 3,604,653 | ||
| Basic (loss) per common share | -0.19 | -0.39 | ||
| Weighted average common shares outstanding (basic) | 4,555,945 | 4,496,108 | ||
Sunshine Biopharma Inc. (SBFMW)
Sunshine Biopharma Inc. (SBFMW)